SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs breakout to a fresh 52-week high has traders focused on the upcoming Q3 report and speculation about a potential pharma buyout, with some interpreting the lack of an earnings-date announcement as a clue. The acquisition talk is unconfirmed; bullish sentiment also reflects BRIUMVIs sales growth and anticipated subcutaneous data, while skeptics warn that earnings and commercial executionnot takeover rumorswill determine the story.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvanas Q3 report, with record revenue and retail-unit growth, alongside the SECs decision to close its investigation without recommending enforcement action, fueled a sharp rally. Bulls point to growth and possible short-covering, while bears focus on the EPS miss, margin pressure, lack of future guidance, and valuation concerns.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,075,967,326.643147 in circulation. The last known price of Algorand is 0.09515711 USD and is down -0.23 over the last 24 hours. It is currently trading on 586 active market(s) with $49,581,617.87 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGO is drawing attention around a contested recovery thesis: bullish traders cite technical support, rebounds and a possible altcoin rotation, while bears point to persistent underperformance and the risk of further declines. Some bulls also highlight Algorands quantum-resistant technology and tokenization or payment use cases, though these are longer-term narratives rather than a confirmed near-term catalyst.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

ALM is drawing attention as its shares sell off despite traders pointing to firm tungsten prices and Almontys Sangdong mine moving into production. The debate centers on whether the decline reflects broader risk-off pressure and uncertainty about the mines ramp-up, or an opportunity backed by tightening tungsten supply.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grummans strong quarterly results, raised full-year outlook and record backlog are driving attention, with traders highlighting sustained defense demand and the stocks post-results strength. Some remain cautious after the defense sectors recent weakness and debate whether the rally can hold.

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Natera Inc

Natera is drawing attention amid reported insider share sales after a sharp run to record highs, with some traders trimming on concern while others view the sales as routine profit-taking. The discussion also reflects debate over the stocks stretched valuation and whether its growth in genetic testing and oncology diagnostics can sustain the rally.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens positive Phase 3 lung-cancer data for IMDELLTRA with AstraZenecas IMFINZIshowing a substantial survival benefithas reinforced optimism about its oncology pipeline as shares reach new highs. Traders are also watching the upcoming earnings report and debating whether heavy options activity reflects bullish positioning or hedging.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

A strong third-quarter earnings beat has driven Regeneron shares sharply higher, with traders citing growth from Dupixent and Eylea HD and the breakout to a new 52-week high. The reaction is largely bullish, though traders are debating whether the rally will hold or fade after the sharp move.

Crown Castle, Inc. engages in the business of owning, operating, and leasing shared communications infrastructure. It operates through the following segments: Towers, Fiber, and Other. The Towers segment focuses on providing coverage and capacity for wireless carrier network deployments. The Fiber segment includes communications infrastructure offerings of small cells and fiber solutions. The Other segment is involved in corporate assets such as cash and cash equivalents. The company was founded by Ted B. Miller Jr. and Edward C. Hutcheson Jr. in 1994 and is headquartered in Houston, TX.

Crown Castle Inc

Crown Castle International Corp

Reports that SpaceX is exploring access to thousands of U.S. cell sites have driven attention to Crown Castle, with traders viewing a potential new tenant as a leasing opportunity for tower owners. The discussions remain unconfirmed and no agreement is signed, prompting debate over whether the growth case is real or the rally is based on speculation about SpaceXs wireless ambitions.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas upcoming addition to the S&P 500 is a major topic, with traders weighing expected index-fund buying against a possible sell-the-news move as the shares weaken. Some posts also cite an alleged DHS-related breach, but those claims are unverified in the discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Okta To Replace Kenvue In S&P 500

(RTTNews) - S&P Dow Jones Indices, a division of S&P Global (SPGI), announced that S&P MidCap 400 constituent Okta Inc. (OKTA) will replace Kenvue Inc. (KVUE) in the S&P 500, S&P SmallCap 600 constituent Glaukos Corp. (GKOS) will replace Okta in the S&P MidCap 400, and McGrath Re...

OKTA vs. S: Which Enterprise Cybersecurity Stock Has an Edge Now?

Okta has an edge over SentinelOne, with stronger profitability, robust cash flow and expanding AI-agent security capabilities despite slower revenue growth.

Okta, Inc. (OKTA) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Okta (OKTA). This makes it worthwhile to examine what the stock has in store.

Josh Brown's 'Best Stocks in the Market': Okta

Josh Brown's 'Best Stocks in the Market': Okta...

Okta Surges 158% YTD: Should Investors Hold the Stock Now?

OKTA shares have surged 157.5% YTD on rising identity security and AI demand, but slowing revenue growth, stiff competition and premium valuation raise concerns.

Can Okta's Agent Identity Platform Capture the AI Security Opportunity?

OKTA expands AI agent security with multimillion-dollar wins and new identity tools, but revenue impact remains limited as adoption develops.

Okta (OKTA) Beats Stock Market Upswing: What Investors Need to Know

Okta (OKTA) closed at $226.07 in the latest trading session, marking a +2.75% move from the prior day.

Top Research Reports for Alphabet, ExxonMobil & Toyota Motor

Alphabet, ExxonMobil and Toyota Motor headline today's top research reports, highlighting AI growth, energy cash generation and hybrid vehicle opportunities.

Cybersecurity ETFs in Spotlight as AI's Black October Unfolds 

AI-discovered vulnerabilities during "Black October" have put cybersecurity ETFs in the spotlight, with four funds posting gains up to 63.9% year to date.

Datadog Reportedly Bids Nearly $4B For Cloud Security Startup Upwind To Fortify AI Defenses 

Equity

Cloud monitoring giant Datadog has reportedly offered nearly $4 billion to acquire cloud security startup Upwind, The Information reported. 


Extremely Bullish Sentiment

<ul class="summary-bullets"><li>Upwind has not accepted the proposal and is concurrently closing a $300 million funding round at a roughly $3.8 billion valuation.</li><li>The takeover discussions underscore a broader industry surge in enterprise spending on security software to protect against AI-driven threats.</li><li>44 out of 48 analysts rate DDOG as ‘buy,’ two say ‘hold,’ and two say ‘sell’.&nbsp;</li></ul>Datadog Inc. (DDOG), a data organization software developer, has set its sights on expanding its security footprint with an attempt to acquire cloud security startup Upwind, as per an exclusive report by The Information.Upwind specializes in software designed to monitor cloud-running applications—including emerging AI agents—while automatically detecting and responding to potential security breaches and hacks.&nbsp;Representatives for Upwind declined to comment on the matter, while Datadog did not immediately respond to The Information’s requests for comment.<h2 class="st-heading-2">Navigating Valuations And Private Funding</h2>While the buyout offer is for approximately $4 billion, Upwind has not yet accepted the proposal. Instead, sources cited by The Information revealed that the startup is simultaneously finalizing a $300 million funding round that values the company at approximately $3.8 billion.Because the buyout bid is closely aligned with this private valuation, it carries very little premium over what the company is already worth independently. Industry insiders note that this tight valuation spread reflects Upwind's strong positioning and investor appetite in the current private market.<h2 class="st-heading-2">Surging AI Security Demand&nbsp;</h2>The merger discussions unfold against a backdrop of sweeping changes in the cybersecurity landscape. The sector has faced intense pressure from AI-related threats after advanced models successfully uncovered major vulnerabilities in widely used software infrastructures.&nbsp;For instance, leaders of the two major AI labs—Anthropic’s Dario Amodei and OpenAI’s Sam Altman—have both publicly called for the need to slow down AI development amid increased cases of AI agents taking decisions of their own accord.&nbsp;These threats have accelerated corporate spending on specialized cybersecurity solutions. This rise in threats has driven a sharp spike in enterprise demand for dedicated software capable of tracking and securing these cloud agents, making security startups like Upwind prime targets for industry consolidation.Other cybersecurity stocks such as CrowdStrike Holdings (CRWD), Palo Alto Networks (PANW), and Okta (OKTA) have all gained between 90% and 130% so far this year amid the increased demand for cloud and system security.<h2 class="st-heading-2"><a class="mention" data-mention="$DDOG" data-symbol-id="DDOG" href="https://stocktwits.com/symbol/DDOG" target="_blank">DDOG Stock</a>: Retail View&nbsp;</h2>Retail sentiment on Stocktwits was ‘neutral’ with ‘normal’ message volumes. Institutional investors, meanwhile, largely have a bullish outlook on the stock, with 44 out of 48 analysts rating DDOG as ‘buy,’ two say ‘hold,’ and two say ‘sell’.&nbsp;DDOG stock has gained about 90% year-to-date.&nbsp;&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Datadog, Inc. logo appears on the screen of a smartphone in Reno, United States, on December 7, 2024. 

Datadog Inc. (DDOG), a data organization software developer, has set its sights on expanding its security footprint with an attempt to acquire cloud security startup Upwind, as per an exclusive report by The Information.

Datadog Reportedly Bids Nearly $4B For Cloud Security Startup Upwind To Fortify AI Defenses

Crowdstrike Holdings Inc

Datadog Inc

Palo Alto Networks Inc

$CRWD

$PANW

$NET

Cybersecurity is one of the market's most crowded trades right now, and $CRWD, $PANW, $NET, and $ZS each represent a different bet on where the next leg of growth comes from. If you had to put your money behind just one for the next 12 months, which are you choosing? Explain your reasoning in the comments.

Which cybersecurity stock will post the best performance over the next 12 months? 
 
Drop a comment for other tickers.

Stocktwits

Stocktwits Polls

Investors are monitoring the upcoming November 4th addition to the S&P 500, anticipating forced buying from passive index funds.

Discussion centers on the sector's long-term defensive role despite headline-driven volatility and lingering fears regarding data breaches.

Current Price	$208.24
Prev Close	$221.86
Open	$219.00
Dividend Yield	0.00%
50-Day Moving Average	$192.78
Beta	1.30
Avg. Volume	4.01M
PE Ratio	125.80

52-Week High	$235.00
52-Week Low	$62.66
Market Capitalization	$36.4B
EPS (Annual)	$1.31
Price to Book	5.22
Revenue Per Employee	$458,529.69

Feed

News

Sentiment

Earnings

Fundamentals

Info

OKTA Fundamentals